Speakers

Sir Andrew Dillon

Chair: On the front line of innovation - insights from the Cancer Drugs Fund and Early Access to Medicines Scheme

Sir Andrew Dillon
Chief Executive
NICE

Sir Andrew Dillon joined the NHS in 1975 and has held a number of senior management positions, including General Manager of the Royal Free Hospital and Chief Executive of St George's Healthcare NHS Trust. He joined the National Institute for Health and Care Excellence as its founding Chief Executive in 1999.

Professor Mark Baker

Session: Update on changes to NICE's guidance manual  

Professor Mark Baker
Centre for Guidelines Director
NICE

Mark Baker is the Director of the Centre for Guidelines (CfG) and is responsible for designing and operating methods and systems to produce clinical guidelines for the NHS. CfG is also responsible for the work of the Medicines and Prescribing Centre including summaries of evidence on new medicines and unlicensed and off-label medicines and the management of the contract for the British National Formulary.

Before joining NICE, Mark was Lead Cancer Clinician at the Leeds Teaching Hospitals and National Clinical Lead for Cancer Peer Review. He has previously worked in transplantation, academic medicine and public health medicine and was Chief Executive of Bradford Teaching Hospitals for six years and a Director of Research and Development. 

Meindert Boysen

Session: Roadmap for life sciences - interactive workshop

Meindert Boysen
Programme Director - HTE Appraisals
NICE

Biog to follow

Nicola Brent

Session: Integrating and leading patient-centred systems

Nicola Brent
Programme Director - System Engagement
NICE

Biog to follow

Paul Chrisp

Session: Implementing the Accelerated Access Review and Getting the most value out of medicines

Paul Chrisp
Programme Director - Medicines and Technologies Programme
NICE

Biog to follow

Professor Alf Collins

Session: Shared decision-making and patient empowerment

Professor Alf Collins
National Policy Advisor, Person-centred Care
NHS England

Biog to follow

Chris Connell

Session: Implementation workshop - After the NICE recommendation: using guidance with limited resources

Chris Connell
Associate Director, NICE Field Team (South)
NICE

Biog to follow

Annie Coppell

Session: Implementation workshop - After the NICE recommendation: using guidance with limited resources

Annie Coppell
Associate Director – Field Team (North) and Sector Lead for Health
NICE

Biog to follow

Diarmaid Crean

Session: Apps and wearables

Diarmaid Crean
Deputy Director of Digital
Public Health England

Biog to follow

Carla Deakin

Sessions: Roadmap for life sciences - interactive workshop and Implementing the Accelerated Access Review

Carla Deakin
Associate Director - NICE office for Market Access
NICE

Biog to follow

Professor David Haslam

Session: Opening chair

Professor David Haslam
Chair
NICE

Professor David Haslam is past-President and past Chairman of Council of the Royal College of General Practitioners, past-President of the British Medical Association, a former vice-chairman of the Academy of Medical Royal Colleges, visiting Professor in Primary Health Care at de Montfort University, Leicester, and Professor of General Practice at the University of Nicosia, Cyprus.

He was a GP in Ramsey, Cambridgeshire, for many years and has been an expert member of the NHS National Quality Board, chair of the NQB Quality Information Committee, and National Clinical Adviser to both the Care Quality Commission and the Healthcare Commission.

David is a Fellow of the:

  • Royal College of GPs
  • Faculty of Public Health
  • Academy of Medical Educators
  • Royal Society of Medicine
  • Royal College of Physicians.

He’s written 13 books, mainly on health topics for the lay public and translated into 13 languages, and well over a thousand articles for the medical and lay press.

In 2014 he was named by Debretts and the Sunday Times as one of the 500 most influential and inspirational people in the United Kingdom. He was awarded a CBE in 2004 for services to medicine and health care, and has been awarded honorary doctorates by the University of Birmingham and the University of East Anglia.  

Johanna Hulme

Session: Tackling antimicrobial resistance globally and locally

Johanna Hulme
Associate Director Medicines Evidence and Advice
NICE

Biog to follow

Celia Ingham-Clark

Session: Uniting the science and practice of clinical improvement

Celia Ingham-Clark
Medical Director for Clinical Effectiveness
NHS England

Biog to follow

Su Jones

Session: Getting the most value out of medicines

Su Jones
NHS Engagement Partner, National lead for Accelerating Access & Uptake
The Association of the British Pharmaceutical Industry

Biog to follow

Gary Leeming

Sessions: What can big data analytics achieve for healthcare?

Gary Leeming
Director of Informatics
Greater Manchester Academic Health Science Network

Biog to follow

Professor Gill Leng

Session: Uniting the science and practice of clinical improvement and Shared decision-making and patient empowerment  

Professor Gill Leng
Deputy Chief Executive and Health and Social Care Director 
NICE

Professor Gillian Leng is the Deputy Chief Executive at NICE, the Director of Health and Social Care, and a visiting professor at King's College London.

Gillian trained in medicine at Leeds, and then spent several years researching the epidemiology of peripheral vascular disease at Edinburgh University. She was involved in the Cochrane Collaboration as it first became established, and still contributes as an editor to the EPOC Group (Effective Practice and Organisation of Care). She specialised in public health medicine, and worked as a consultant before moving to NICE in 2001.

At NICE, Gillian has been responsible for the initial set up and running of the clinical guidelines programme, for establishing the NICE implementation function, and for setting up NHS Evidence. More recently she has been responsible for the transfer of the National Prescribing Centre into NICE, for establishing the NICE accreditation programme, and for new work on Quality Standards across health and social care.

Gillian is also Director of the Health and Social Care Programme and since January 2015 is leading the public health team at NICE.

Professor Carole Longson

Session: On the front line of innovation - insights from the Cancer Drugs Fund and Early Access to Medicines Scheme  

Professor Carole Longson
Centre for Health Technology Evaluation Director
NICE

Carole is Director of the Centre for Health Technology Evaluation at NICE. She has a doctorate in Pharmacology and spent 8 years at GlaxoSmithKline Research working on the development of novel pharmaceuticals in various therapeutic areas.

Carole has previously been involved in health technology assessment as Director of the Evidence Research Unit. She contributes to a number of international policy forums, including the WHO advisory group on Priority Medical Devices and the Scientific Committee of the Innovative Medicines Initiative. She is Honorary Professor of Health Technology Assessment at the University of Manchester, UK and past President of Health Technology Assessment International (2013 to 2015).

Mirella Marlow

Session: MedTechScan - Speeding up adoption of innovative devices and diagnostics

Mirella Marlow
Programme Director Devices and Diagnostic Systems
NICE

Biog to follow

Steve Turner

Session: Managing care for patients with multimorbidities - case studies of implementing NICE guidance

Steve Turner
NICE Medicines and Prescribing Centre Associate
Care Right Now

Biog to follow

Harriet Unsworth

Session: Apps and wearables

Harriet Unsworth
Senior Technical Analyst
NICE

Biog to follow

Paula Whitty

Session: Implementation workshop - After the NICE recommendation: using guidance with limited resources

Paula Whitty
Joint Director of Research, Innovation and Clinical Effectiveness
Northumberland, Tyne and Wear NHS Foundation Trust

Biog to follow